150 related articles for article (PubMed ID: 6194683)
1. The behavior of antithrombin III, alpha 2 macroglobulin, and alpha 1 antitrypsin during cardiopulmonary bypass.
Pickering NJ; Brody JI; Fink GB; Finnegan JO; Ablaza S
Am J Clin Pathol; 1983 Oct; 80(4):459-64. PubMed ID: 6194683
[TBL] [Abstract][Full Text] [Related]
2. Blood levels of proteinase inhibitors in pregnancy.
Walker JE; Campbell DM; Ogston D
Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
[TBL] [Abstract][Full Text] [Related]
3. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
[TBL] [Abstract][Full Text] [Related]
4. Blood levels of proteinase inhibitors in pre-eclampsia.
Gow L; Campbell DM; Ogston D
Br J Obstet Gynaecol; 1983 Oct; 90(10):950-2. PubMed ID: 6194812
[TBL] [Abstract][Full Text] [Related]
5. [Functional properties of thrombocytes and inhibitors of proteolytic enzymes of the blood in patients with acute forms of ischemic heart disease].
Kakuliia MSh; Panchenko VM
Kardiologiia; 1988 May; 28(5):42-6. PubMed ID: 2457730
[TBL] [Abstract][Full Text] [Related]
6. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H
Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease.
Bohe M; Genell S; Ohlsson K
Scand J Gastroenterol; 1986 Jun; 21(5):598-604. PubMed ID: 2428096
[TBL] [Abstract][Full Text] [Related]
8. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
[TBL] [Abstract][Full Text] [Related]
9. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
10. Studies of protease inhibitors in the sera of patients with amyotrophic lateral sclerosis.
Adachi N; Shoji S
J Neurol Sci; 1989 Feb; 89(2-3):165-8. PubMed ID: 2466958
[TBL] [Abstract][Full Text] [Related]
11. Circulating antithrombins in pregnancy.
Teisner B; Davey MW; Grudzinskas JG
Br J Obstet Gynaecol; 1982 Jan; 89(1):62-4. PubMed ID: 6174143
[TBL] [Abstract][Full Text] [Related]
12. Complement and protease inhibitors in the mucocutaneous lymph node syndrome.
Rieger CH; Kawasaki T; Yanase Y; Pollack U
Eur J Pediatr; 1983 Apr; 140(2):92-7. PubMed ID: 6192994
[TBL] [Abstract][Full Text] [Related]
13. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
14. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
Rothschild BM; Thompson LD; Pifer DD; Chesney CM
Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
[TBL] [Abstract][Full Text] [Related]
15. Familial thrombosis due to antithrombin III deficiency in a Greek family.
Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of some blood coagulation parameters in angiographically documented coronary arteriosclerosis].
Panizza P; Majolino I; Nalli G; Mussini A
Haematologica; 1981 Dec; 66(6):768-78. PubMed ID: 6175552
[No Abstract] [Full Text] [Related]
17. Changes in protease inhibitors after acute myocardial infarction.
Rennie JA; Crawford GP; Ogston D
J Clin Pathol; 1976 Jul; 29(7):639-41. PubMed ID: 61974
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
[No Abstract] [Full Text] [Related]
19. Inhibition of human factor Xa by various plasma protease inhibitors.
Ellis V; Scully M; MacGregor I; Kakkar V
Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
[TBL] [Abstract][Full Text] [Related]
20. [Hemostasis in untreated acute leukemia. II. Natural inhibitors: biological and immunological activity. Immunologic variation of antithrombin III].
Kordich L; Sassetti B; Lago O
Sangre (Barc); 1984; 29(2):133-40. PubMed ID: 6206579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
